Paediatric Healthcare Market
Paediatric Healthcare Market Forecasts to 2030 - Global Analysis By Treatment Type (Medications, Surgical Procedures, Preventive Care, Therapy and Other Treatment Types), Drug Type, Age Group, Indication, Application, End User and By Geography
|
Years Covered |
2022-2030 |
|
Estimated Year Value (2024) |
US $14.7 BN |
|
Projected Year Value (2030) |
US $20.0 BN |
|
CAGR (2024 - 2030) |
6.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Paediatric Healthcare Market is accounted for $14.7 billion in 2024 and is expected to reach $20.0 billion by 2030 growing at a CAGR of 6.4% during the forecast period. Providing medical care, treatment, and preventative services to newborns, kids, and teenagers up to the age of eighteen is the specialty of pediatric healthcare. Neonatal care, vaccinations, illness prevention, and the diagnosis, treatment, and management of long-term problems such as diabetes, asthma, and congenital disorders are all included. Nutritional counselling and immunization programs are important preventive interventions. To provide individualized care, paediatricians, nurses, and specialists work in tandem with parents. Global access to high-quality pediatric care has been enhanced by developments in telemedicine, medical technology, and AI-driven diagnostics.
According to Observer Research Foundation data published in December 2021, India has nearly 200 million undernourished people. Infectious disorders continue to be the primary causes of death among children under the age of five around the world.
Market Dynamics:
Driver:
Increasing prevalence of chronic illnesses
Chronic illnesses among children, such as asthma, diabetes, and obesity conditions require ongoing medical attention and specialized care, leading to a higher demand for paediatric healthcare services. Additionally, early diagnosis and intervention are critical for managing chronic illnesses, further emphasizing the need for advanced diagnostic tools and treatment options. The growing awareness among parents about the importance of regular health check-ups for their children is also contributing to the market's growth.
Restraint:
High treatment costs & limited insurance coverage
Specialized care for children with chronic illnesses or complex medical conditions can be prohibitively expensive, making it difficult for many families to afford the necessary treatments. Furthermore, not all insurance plans provide adequate coverage for paediatric healthcare services, leading to out-of-pocket expenses for families. The financial burden associated with medical treatments can deter parents from seeking timely and appropriate care for their children. Efforts to improve insurance coverage and reduce treatment costs are essential to ensure that all children have access to quality healthcare services.
Opportunity:
Increased awareness of child health & nutrition
Parents and caregivers are becoming more informed about the importance of a balanced diet, regular exercise, and preventive healthcare for their children. This heightened awareness is driving demand for health education programs, nutritional counselling, and wellness services. Schools and community organizations are also playing a role in promoting healthy lifestyle choices among children. As a result, paediatric healthcare providers are expanding their services to include comprehensive health and wellness programs that address the physical, mental, and emotional well-being of children.
Threat:
Shortage of paediatric specialists
The growing demand for paediatricians, paediatric nurses, and other specialized healthcare professionals is not being met with an adequate supply. This shortage can lead to longer wait times for appointments, reduced access to specialized care, and increased workloads for existing healthcare providers. The lack of paediatric specialists can also impact the quality of care provided to children, particularly those with complex medical conditions requiring specialized expertise impeding the market growth.
Covid-19 Impact
The COVID-19 pandemic has had a profound impact on the paediatric healthcare market. The pandemic led to the postponement of non-urgent medical procedures and routine check-ups, affecting overall healthcare utilization for children. However, the need for remote consultations and telehealth services surged, providing continued access to medical care for children during lockdowns. The pandemic also heightened awareness about the importance of vaccinations and preventive healthcare for children.
The surgical procedures segment is expected to be the largest during the forecast period
The surgical procedures segment is expected to account for the largest market share during the forecast period due to increasing number of paediatric surgeries for congenital anomalies, trauma, and other medical conditions requiring surgical intervention. Advances in minimally invasive surgical techniques and the availability of specialized surgical equipment for paediatric patients further contribute to the segment's growth. The rise in awareness about the importance of early surgical intervention for better health outcomes also supports the demand for paediatric surgical procedures.
The neonates (0-28 days) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the neonates (0-28 days) segment is predicted to witness the highest growth rate owing to increasing focus on neonatal care, driven by rising preterm birth rates and neonatal health complications, is a key factor contributing to this growth. Advances in neonatal intensive care units (NICUs) and the availability of specialized medical equipment for newborns support the segment's expansion. Additionally, government initiatives and programs aimed at reducing neonatal mortality rates and improving the quality of care for newborns further drive the demand for neonatal healthcare services.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share owing to region's well-established healthcare infrastructure, high healthcare expenditure, and the presence of major paediatric healthcare providers contribute to its dominant position. Additionally, the increasing prevalence of chronic illnesses among children and the rising demand for specialized paediatric care drive the market growth in North America. Government initiatives and policies aimed at improving child health and reducing infant mortality rates further support the expansion of paediatric healthcare services.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR attributed rapid growth of the paediatric healthcare market in this region is driven by the increasing prevalence of chronic illnesses, rising healthcare expenditure, and the expansion of healthcare infrastructure. Countries like China and India are at the forefront of this growth, with government initiatives aimed at improving child health and reducing infant mortality rates. The growing awareness among parents about the importance of preventive healthcare and regular check-ups for children further supports the market expansion.
Key players in the market
Some of the key players in Paediatric Healthcare market include Abbott Laboratories, BAYADA Home Health Care, Boehringer Ingelheim International GmbH, BrightStar Care, Eisai Co., Eli Lilly and Company, EnViva Paediatric Care, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Novartis International AG, Pfizer Inc, Sanofi S A, Tendercare Home Health, The Procter & Gamble Company and Viatris.
Key Developments:
In January 2025, Eli Lilly and Company and Scorpion Therapeutics, Inc announced a definitive agreement for Lilly to acquire Scorpion's PI3Kα inhibitor program STX-478. STX-478 is a once-daily oral, mutant-selective PI3Kα inhibitor currently being evaluated in a Phase 1/2.
In January 2025, Johnson & Johnson and Intra-Cellular Therapies, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies.
In December 2024, Abbott announced it has reached an agreement with DexCom, Inc. to settle all outstanding patent disputes between the companies in cases related to continuous glucose monitoring products.
Treatment Types Covered:
• Medications
• Surgical Procedures
• Preventive Care
• Therapy
• Other Treatment Types
Drug Types Covered:
• Antibiotics
• Analgesics and Pain Medications
• Antipyretics
• Antiallergy Drugs
• Anti-inflammatory Drugs
• Antiviral Drugs
• Anticonvulsants
• Chemotherapy Drugs
Age Groups Covered:
• Neonates (0-28 days)
• Infants (1 month - 1 year)
• Toddlers (1-3 years)
• Preschoolers (3-5 years)
• School-aged Children (6-12 years)
Indications Covered:
• Asthma & Allergies
• Cardiac Disorders
• Genetic Disorders
• Diabetes
• Obesity
• Other Indications
Applications Covered:
• Paediatric Specialty Care
• Emergency & Critical Care
• Mental & Behavioural Health
• Home Healthcare & Telemedicine
• Disease Treatment & Management
• Other Applications
End Users Covered:
• Hospitals
• Clinics & Ambulatory Care Centres
• Research & Academic Institutions
• Government & Non-Governmental Organizations
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Paediatric Healthcare Market, By Treatment Type
5.1 Introduction
5.2 Medications
5.3 Surgical Procedures
5.4 Preventive Care
5.5 Therapy
5.6 Other Treatment Types
6 Global Paediatric Healthcare Market, By Drug Type
6.1 Introduction
6.2 Antibiotics
6.3 Analgesics and Pain Medications
6.4 Antipyretics
6.5 Antiallergy Drugs
6.6 Anti-inflammatory Drugs
6.7 Antiviral Drugs
6.8 Anticonvulsants
6.9 Chemotherapy Drugs
7 Global Paediatric Healthcare Market, By Age Group
7.1 Introduction
7.2 Neonates (0-28 days)
7.3 Infants (1 month - 1 year)
7.4 Toddlers (1-3 years)
7.5 Preschoolers (3-5 years)
7.6 School-aged Children (6-12 years)
8 Global Paediatric Healthcare Market, By Indication
8.1 Introduction
8.2 Asthma & Allergies
8.3 Cardiac Disorders
8.4 Genetic Disorders
8.5 Diabetes
8.6 Obesity
8.7 Other Indications
9 Global Paediatric Healthcare Market, By Application
9.1 Introduction
9.2 Paediatric Specialty Care
9.3 Emergency & Critical Care
9.4 Mental & Behavioural Health
9.5 Home Healthcare & Telemedicine
9.6 Disease Treatment & Management
9.7 Other Applications
10 Global Paediatric Healthcare Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Clinics & Ambulatory Care Centres
10.4 Research & Academic Institutions
10.5 Government & Non-Governmental Organizations
10.6 Other End Users
11 Global Paediatric Healthcare Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott Laboratories
13.2 BAYADA Home Health Care
13.3 Boehringer Ingelheim International GmbH
13.4 BrightStar Care
13.5 Eisai Co.
13.6 Eli Lilly and Company
13.7 EnViva Paediatric Care
13.8 Gilead Sciences
13.9 GlaxosmithklinePlc
13.10 Johnson & Johnson
13.11 Novartis International AG
13.12 Pfizer Inc
13.13 Sanofi S A
13.14 Tendercare Home Health
13.15 The Procter & Gamble Company
13.16 Viatris
List of Tables
1 Global Paediatric Healthcare Market Outlook, By Region (2022-2030) ($MN)
2 Global Paediatric Healthcare Market Outlook, By Treatment Type (2022-2030) ($MN)
3 Global Paediatric Healthcare Market Outlook, By Medications (2022-2030) ($MN)
4 Global Paediatric Healthcare Market Outlook, By Surgical Procedures (2022-2030) ($MN)
5 Global Paediatric Healthcare Market Outlook, By Preventive Care (2022-2030) ($MN)
6 Global Paediatric Healthcare Market Outlook, By Therapy (2022-2030) ($MN)
7 Global Paediatric Healthcare Market Outlook, By Other Treatment Types (2022-2030) ($MN)
8 Global Paediatric Healthcare Market Outlook, By Drug Type (2022-2030) ($MN)
9 Global Paediatric Healthcare Market Outlook, By Antibiotics (2022-2030) ($MN)
10 Global Paediatric Healthcare Market Outlook, By Analgesics and Pain Medications (2022-2030) ($MN)
11 Global Paediatric Healthcare Market Outlook, By Antipyretics (2022-2030) ($MN)
12 Global Paediatric Healthcare Market Outlook, By Antiallergy Drugs (2022-2030) ($MN)
13 Global Paediatric Healthcare Market Outlook, By Anti-inflammatory Drugs (2022-2030) ($MN)
14 Global Paediatric Healthcare Market Outlook, By Antiviral Drugs (2022-2030) ($MN)
15 Global Paediatric Healthcare Market Outlook, By Anticonvulsants (2022-2030) ($MN)
16 Global Paediatric Healthcare Market Outlook, By Chemotherapy Drugs (2022-2030) ($MN)
17 Global Paediatric Healthcare Market Outlook, By Age Group (2022-2030) ($MN)
18 Global Paediatric Healthcare Market Outlook, By Neonates (0-28 days) (2022-2030) ($MN)
19 Global Paediatric Healthcare Market Outlook, By Infants (1 month - 1 year) (2022-2030) ($MN)
20 Global Paediatric Healthcare Market Outlook, By Toddlers (1-3 years) (2022-2030) ($MN)
21 Global Paediatric Healthcare Market Outlook, By Preschoolers (3-5 years) (2022-2030) ($MN)
22 Global Paediatric Healthcare Market Outlook, By School-aged Children (6-12 years) (2022-2030) ($MN)
23 Global Paediatric Healthcare Market Outlook, By Indication (2022-2030) ($MN)
24 Global Paediatric Healthcare Market Outlook, By Asthma & Allergies (2022-2030) ($MN)
25 Global Paediatric Healthcare Market Outlook, By Cardiac Disorders (2022-2030) ($MN)
26 Global Paediatric Healthcare Market Outlook, By Genetic Disorders (2022-2030) ($MN)
27 Global Paediatric Healthcare Market Outlook, By Diabetes (2022-2030) ($MN)
28 Global Paediatric Healthcare Market Outlook, By Obesity (2022-2030) ($MN)
29 Global Paediatric Healthcare Market Outlook, By Other Indications (2022-2030) ($MN)
30 Global Paediatric Healthcare Market Outlook, By Application (2022-2030) ($MN)
31 Global Paediatric Healthcare Market Outlook, By Paediatric Specialty Care (2022-2030) ($MN)
32 Global Paediatric Healthcare Market Outlook, By Emergency & Critical Care (2022-2030) ($MN)
33 Global Paediatric Healthcare Market Outlook, By Mental & Behavioural Health (2022-2030) ($MN)
34 Global Paediatric Healthcare Market Outlook, By Home Healthcare & Telemedicine (2022-2030) ($MN)
35 Global Paediatric Healthcare Market Outlook, By Disease Treatment & Management (2022-2030) ($MN)
36 Global Paediatric Healthcare Market Outlook, By Other Applications (2022-2030) ($MN)
37 Global Paediatric Healthcare Market Outlook, By End User (2022-2030) ($MN)
38 Global Paediatric Healthcare Market Outlook, By Hospitals (2022-2030) ($MN)
39 Global Paediatric Healthcare Market Outlook, By Clinics & Ambulatory Care Centres (2022-2030) ($MN)
40 Global Paediatric Healthcare Market Outlook, By Research & Academic Institutions (2022-2030) ($MN)
41 Global Paediatric Healthcare Market Outlook, By Government & Non-Governmental Organizations (2022-2030) ($MN)
42 Global Paediatric Healthcare Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
